| Catalog Number |
363705 |
| Medical Device Problem Code |
Coagulation in Device or Device Ingredient (1096)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
07/27/2023
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
H.3.A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
|
| |
|
Event or Problem Description
|
|
It was reported that while using tube micro k2 edta lav map ce that there there were clotting/micro clots/fibrin clots.This occurred 10 times.The following information was provided by the initial reporter: short description: samples coagulation.When did the incident occur? after use.After sampling, some tubes show coagulation and clotting.
|
| |
|
Additional Manufacturer Narrative
|
|
The following fields have been updated with additional information: d4.Medical device lot #: updated to 2139564 from clarification provided by complainant.D4.Medical device expiration date: updated to 30-nov-2023 from clarification provided by complainant.D10.Device available for eval- yes.D10.Returned to manufacturer on: 04-jan-2024.H3.Device returned to manufacturer- yes.H3.Device eval by manufacturer- yes.H4.Device manufacture date: updated to 19-may-2022 from clarification provided by complainant.H.6.Investigation summary: bd had received 12 samples and 0 photos for investigation.The returned samples were tested but due to a reagent issue, the results were not conclusive.Therefore, 45 retention samples from bd inventory were visually inspected with no issues observed.Additionally, 5 retention samples were further analyzed for edta content and all were within specification.Complaints for sample quality are under statistical control for the month of august 2023.At this time, further testing is not indicated.Based on a review of the device history record for the incident lot, all product specifications and requirements for lot release were met.There were no related quality issues during manufacturing of the product.This complaint is unable to be confirmed for the indicated failure mode clotting.Bd was not able to identify a root cause for the indicated failure mode.Complaints received for this device and reported condition will continue to be tracked and trended.Our business team regularly reviews the collected data for identification of emerging trends.Bd quality will continue to monitor sample quality complaints.
|
| |
|
Event or Problem Description
|
|
It was reported that while using tube micro k2 edta lav map ce that there were clotting/micro clots/fibrin clots.This occurred 10 times.The following information was provided by the initial reporter: short description: samples coagulation when did the incident occur? after use after sampling, some tubes show coagulation and clotting.
|
| |
|
Search Alerts/Recalls
|